no statement of use filed
on 08 Apr 2024
Last Applicant/ Owned by
Route 206 & Province Line Road
Princeton
NJ
08543
Serial Number
97690367 filed on 23rd Nov 2022
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprol Read More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use
No 97690367
No Service/Collective Mark
No 00161737-US
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
08th Apr 2024 | ABANDONMENT - NO USE STATEMENT FILED |
08th Apr 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
05th Sep 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
02th Aug 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
02th Aug 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
02th Aug 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
11th Jul 2023 | PUBLISHED FOR OPPOSITION |
11th Jul 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
21st Jun 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
04th Jun 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |